| Detected | Trial | Change |
|---|---|---|
| 2026-05-27 | NCT05769153 Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD) |
date change Primary completion moved earlier: 2027-10 -> 2027-05 |
| 2026-05-20 | NCT05769153 Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD) |
overall status: "Recruiting" → "Active Not Recruiting" |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06709339 | Study to Investigate the Efficacy, Safety and Durability of Faricimab in Caucasian… | Polypoidal Choroidal Vasculopathy | Recruiting |
| NCT07367282 | Evaluate the Efficacy of Faricimab in Patients With Neovascular Age-related Macular… | Macular Degeneration | Not Yet Recruiting |
| Phase 3 | |||
| NCT07461441 | Efficacy and Durability of a Personalized Treat-and-extend Regimen of Faricimab for… | Polypoidal Choroidal Vasculopathy (PCV) | Recruiting |
| Phase 1/2 | |||
| NCT05769153 | Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD) | Neovascular Age-related Macular Degeneration (nAMD) | Active, Not Recruiting |